Medical Device Maker Highlights China Risk as Chinese U.S. IPOs Resume

Meihua International’s updated prospectus includes new section on Beijing’s intent to ‘exert more oversight and control’ over overseas Chinese listings Key Takeaways: Meihua International files updated prospectus highlighting China oversight risk in latest filing for its modest $57 million U.S. IPO Hotel operator Atour makes similar updated filing for U.S. IPO plan to raise $350 million, valuing the company at more than $2 billion By Doug Young It’s a new week, with yet more signs that the China-U.S. IPO pipeline is slowly creaking back to life. This time it’s a…

Read More